Decision to move to one funded brand of lamotrigine (Logem)

Pharmac have decided from 1 October to fund one brand of lamotrigine 25 mg, 50 mg and 100 mg dispersible tablets (Logem), rather than three different brands (Lamictal, Arrow-Lamotrigine and Logem) and people will be able to collect a three-month supply of Logem from their community pharmacy.

Lamictal 25mg, 50mg and 100mg tablets will remain available in New Zealand for private purchase

To ensure accessibility and affordability for patients who wish to remain on Lamictal after 30 September 2019, GlaxoSmithKline New Zealand (GSK) have reduced the prices for private purchase.

Below are the approximate prices you may be expected to pay at your local pharmacies.

Product

Approximate Private Purchase Price from 1 Oct 2019
(Ask your local pharmacy) including GST

Lamictal 25mg Tablet x 56 $13.00
Lamictal 50mg Tablet x 56 $25.00
Lamictal 100mg Tablet x 56 $37.00

Please note that Lamictal 25mg, 50mg, 100mg tablets will remain funded until 30 September 2019.
Should you have any queries, please consult your healthcare professional.

Last modified: August 1st, 2019 by EWCT | Posted in: News